The high mortality rate of hepatocellular carcinoma (HCC) is primarily due to its late diagnosis. In the past, numerous attempts have been made to design genetic biomarkers for …
CancerEnD is an integrated resource developed for annotating 8524 unique expressed enhancers, associated genes, somatic mutations and copy number variations of 8063 …
Purpose Intra-tumor heterogeneity and high mortality among patients with non-small-cell lung carcinoma (NSCLC) emphasize the need to identify reliable prognostic markers unique …
Hepatocellular carcinoma (HCC) is the most frequent primary malignancy of the liver. The aim of this study is to evaluate the comparative in silico and in vivo ameliorative potential of …
H Zhao, S Zhang, X Yin, C Zhang, L Wang… - Frontiers in …, 2022 - frontiersin.org
Breast cancer is a cancer of high complexity and heterogeneity, with differences in prognosis and survival among patients of different subtypes. Copy number variations …
D Zuo, Y Chen, X Zhang, Z Wang, W Jiang… - Cancer Biology & …, 2022 - ncbi.nlm.nih.gov
Objective: The main reasons for the poor prognoses of pancreatic adenocarcinoma (PA) patients are rapid early-stage progression, advanced stage metastasis, and chemotherapy …
A Grenda, P Krawczyk - Critical Reviews™ in Eukaryotic Gene …, 2021 - dl.begellhouse.com
Genome analyses using next-generation sequencing are providing more and more information on DNA sequences. However, there is a trend towards the return to RNA …
W Huang, W Weng, B Wu, T Ye, Z Lin, Z Zhang… - …, 2021 - Taylor & Francis
Aim: To develop a trans-omics-based molecular clinicopathological algorithm for predicting pancreatic adenocarcinoma prognosis, we performed a comprehensive analysis of the …
P Wang, M Xie, D Yang, F Wang, E Chen - 2022 - researchsquare.com
Objective Cyclin-Dependent Kinases (CDKs) get widely involved in cancer development. However, A wealth of conflicting data raise the question of whether CDKs serve as …